Literature DB >> 23040236

Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections.

Ya-Ting Chang1, Chun-Yu Lin2, Po-Liang Lu3, Chung-Chih Lai1, Tun-Chieh Chen4, Chi-Yu Chen1, Deng-Chyang Wu5, Tzu-Pin Wang6, Chiu-Mei Lin7, Wei-Ru Lin8, Yen-Hsu Chen2.   

Abstract

BACKGROUND/
PURPOSE: Stenotrophomonas maltophilia has been recognized as an important nosocomial pathogen, but few reports have discussed S. maltophilia infection in the community settings. This study aimed to reveal characteristics of patients with community-onset S. maltophilia bloodstream infection (SMBSI), to specify the subgroup of healthcare-associated (HCA) infection in the community-onset group and to compare them with hospital-acquired (HA) SMBSI patients.
MATERIALS AND METHODS: Medical charts of adult patients with SMBSI presenting to a medical center in southern Taiwan from May 2008 to October 2011 were reviewed and analyzed retrospectively.
RESULTS: Among 153 patients, we observed a high percentage (38.6%) of SMBSI to be community onset. Among community-onset SMBSI, 45.8% were community-acquired (CA) and 54.2% were HCA. The crude mortality rates were 11.1%, 18.8%, and 60.6% in the CA, HCA, and HA groups, respectively. Structural/mechanical abnormalities were observed in 32.7% of all cases, and 60% of those were related to malignancy. Independent risk factors for mortality in community-onset SMBSI were liver cirrhosis, liver metastasis, and a high Pitt bacteremia score, whereas structural/mechanical abnormalities and a high Pitt bacteremia score related to increased mortality in HA SMBSI.
CONCLUSION: Community-onset S. maltophilia infection deserves attention. Patients with community-onset SMBSI have reduced disease severity and lower mortality rate when compared to HA SMBSI. Underlying structural/mechanical abnormalities, especially those caused by malignancies, are common in SMBSI cases and should be investigated when bacteremia occurs.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Keywords:  Bacteremia; Bloodstream infection; Community; Healthcare; Mortality; Stenotrophomonas maltophilia

Mesh:

Year:  2012        PMID: 23040236     DOI: 10.1016/j.jmii.2012.08.014

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  19 in total

1.  Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.

Authors:  Consuelo Velázquez-Acosta; Sugehily Zarco-Márquez; Mari Carmen Jiménez-Andrade; Patricia Volkow-Fernández; Patricia Cornejo-Juárez
Journal:  Support Care Cancer       Date:  2018-01-07       Impact factor: 3.603

2.  Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012.

Authors:  M-R Lee; H-C Wang; C-Y Yang; C-K Lin; H-Y Kuo; J-C Ko; W-H Sheng; L-N Lee; C-J Yu; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-24       Impact factor: 3.267

3.  Stenotrophomonas maltophilia Serine Protease StmPr1 Induces Matrilysis, Anoikis, and Protease-Activated Receptor 2 Activation in Human Lung Epithelial Cells.

Authors:  Ashley L DuMont; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

4.  Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia.

Authors:  Mustafa Gokhan Gozel; Cem Celik; Nazif Elaldi
Journal:  Jundishapur J Microbiol       Date:  2015-08-22       Impact factor: 0.747

5.  Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome.

Authors:  Vu Quoc Dat; Hieu Ngoc Vu; Hung Nguyen The; Hoa Thi Nguyen; Long Bao Hoang; Dung Vu Tien Viet; Chi Linh Bui; Kinh Van Nguyen; Trung Vu Nguyen; Dao Tuyet Trinh; Alessandro Torre; H Rogier van Doorn; Behzad Nadjm; Heiman F L Wertheim
Journal:  BMC Infect Dis       Date:  2017-07-12       Impact factor: 3.090

6.  Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.

Authors:  Hirotaka Ebara; Hideharu Hagiya; Yuto Haruki; Eisei Kondo; Fumio Otsuka
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

7.  Surveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy.

Authors:  Jin Zhao; Yubin Xing; Wei Liu; Wentao Ni; Chuanqi Wei; Rui Wang; Yunxi Liu; Youning Liu
Journal:  Front Microbiol       Date:  2016-10-26       Impact factor: 5.640

Review 8.  Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.

Authors:  Ya-Ting Chang; Chun-Yu Lin; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2015-09-02       Impact factor: 5.640

9.  In vitro interaction of Stenotrophomonas maltophilia with human monocyte-derived dendritic cells.

Authors:  Emanuela Roscetto; Laura Vitiello; Rosa Muoio; Amata A Soriano; Vita D Iula; Antonio Vollaro; Eliana De Gregorio; Maria R Catania
Journal:  Front Microbiol       Date:  2015-07-16       Impact factor: 5.640

10.  Phylogenetic analysis of Stenotrophomonas spp. isolates contributes to the identification of nosocomial and community-acquired infections.

Authors:  Vinicius Godoy Cerezer; Silvia Yumi Bando; Jacyr Pasternak; Marcia Regina Franzolin; Carlos Alberto Moreira-Filho
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.